Insider Buy/Sell Details for the Biotechnology Industry — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (936)
AbCellera Biologics Inc. (ABCL)
Thermopylae Holdings Ltd. — 10% Owner
Shares
38,000
Price
$3.44
Total Value
$130.72K
Shares Held After
56,134,097
% of Holdings
0.1%
FibroBiologics, Inc. (FBLG)
GARCIA RUBEN A — General Counsel
Shares
40,000
Price
$0.33
Total Value
$13.06K
Shares Held After
180,000
% of Holdings
22.2%
PALVELLA THERAPEUTICS, INC. (PVLA)
HERON ELAINE J — Director
Shares
2,400
Price
$125.00
Total Value
$300.00K
Shares Held After
47,812
% of Holdings
5.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
JENKINS GEORGE M — Director
Shares
4,000
Price
$125.00
Total Value
$500.00K
Shares Held After
187,171
% of Holdings
2.1%
AbCellera Biologics Inc. (ABCL)
Booth Andrew — Chief Financial Officer
Shares
42,600
Price
$3.42
Total Value
$145.69K
Shares Held After
195,600
% of Holdings
21.8%
Arcellx, Inc. (ACLX)
Elghandour Rami — Director
Shares
89,916
Price
$113.92
Total Value
$10.24M
Shares Held After
276,051
% of Holdings
24.6%
Edesa Biotech, Inc. (EDSA)
Brooks Michael J — President
Shares
2,000
Price
$1.57
Total Value
$3.14K
Shares Held After
226,870
% of Holdings
0.9%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
20,571
Price
$1.58
Total Value
$32.48K
Shares Held After
615,797
% of Holdings
3.3%
Jazz Pharmaceuticals plc (JAZZ)
Carr Patricia — SVP, Chief Accounting Officer
Shares
1,253
Price
$194.11
Total Value
$243.22K
Shares Held After
10,352
% of Holdings
10.8%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
200
Price
$103.96
Total Value
$20.79K
Shares Held After
59,634
% of Holdings
0.3%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
2,602
Price
$103.41
Total Value
$269.07K
Shares Held After
59,834
% of Holdings
4.2%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
2,698
Price
$102.64
Total Value
$276.92K
Shares Held After
62,436
% of Holdings
4.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Ambrose Kristen — SVP & Chief Accounting Officer
Shares
357
Price
$483.36
Total Value
$172.56K
Shares Held After
6,624
% of Holdings
5.1%
Bicara Therapeutics Inc. (BCAX)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
300,000
Price
$16.00
Total Value
$4.80M
Shares Held After
4,603,418
% of Holdings
6.5%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
197
Price
$193.60
Total Value
$38.14K
Shares Held After
58,818
% of Holdings
0.3%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
1,009
Price
$192.79
Total Value
$194.53K
Shares Held After
59,015
% of Holdings
1.7%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
1,784
Price
$191.88
Total Value
$342.31K
Shares Held After
60,024
% of Holdings
2.9%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
549
Price
$190.80
Total Value
$104.75K
Shares Held After
61,808
% of Holdings
0.9%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
1,061
Price
$190.00
Total Value
$201.59K
Shares Held After
62,357
% of Holdings
1.7%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
3,523
Price
$193.58
Total Value
$681.99K
Shares Held After
63,418
% of Holdings
5.3%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
11,529
Price
$191.65
Total Value
$2.21M
Shares Held After
66,941
% of Holdings
14.7%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
2,916
Price
$189.81
Total Value
$553.49K
Shares Held After
68,391
% of Holdings
4.1%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
15,555
Price
$190.28
Total Value
$2.96M
Shares Held After
68,391
% of Holdings
18.5%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
875
Price
$192.07
Total Value
$168.06K
Shares Held After
56,862
% of Holdings
1.5%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
16,602
Price
$192.53
Total Value
$3.20M
Shares Held After
56,862
% of Holdings
22.6%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
200
Price
$104.25
Total Value
$20.85K
Shares Held After
58,117
% of Holdings
0.3%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
2,300
Price
$103.44
Total Value
$237.91K
Shares Held After
58,317
% of Holdings
3.8%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
3,000
Price
$102.64
Total Value
$307.92K
Shares Held After
60,617
% of Holdings
4.7%
Jazz Pharmaceuticals plc (JAZZ)
Henderson Mary Elizabeth — SVP, Technical Operations
Shares
5,343
Price
$194.49
Total Value
$1.04M
Shares Held After
28,728
% of Holdings
15.7%
AbCellera Biologics Inc. (ABCL)
Thermopylae Holdings Ltd. — 10% Owner
Shares
177,457
Price
$3.27
Total Value
$580.28K
Shares Held After
56,096,097
% of Holdings
0.3%
BridgeBio Pharma, Inc. (BBIO)
Apuli Maricel — Chief Accounting Officer
Shares
2,000
Price
$66.00
Total Value
$132.00K
Shares Held After
121,945
% of Holdings
1.6%
Wave Life Sciences Ltd. (WVE)
Francis Chris — SVP, Corporate Development, Head of Emerging Areas
Shares
15,294
Price
$15.00
Total Value
$229.41K
Shares Held After
61,867
% of Holdings
19.8%
Wave Life Sciences Ltd. (WVE)
Francis Chris — SVP, Corporate Development, Head of Emerging Areas
Shares
17,900
Price
$15.09
Total Value
$270.18K
Shares Held After
61,867
% of Holdings
22.4%
Axsome Therapeutics, Inc. (AXSM)
Coleman Mark — Director
Shares
25,000
Price
$161.11
Total Value
$4.03M
Shares Held After
47,140
% of Holdings
34.7%
Axsome Therapeutics, Inc. (AXSM)
Jacobson Mark L. — Chief Operating Officer
Shares
35,378
Price
$161.88
Total Value
$5.73M
Shares Held After
0
% of Holdings
100.0%
Climb Bio, Inc. (CLYM)
Thomas Stephen Basil — Director
Shares
16,313
Price
$7.01
Total Value
$114.29K
Shares Held After
154,657
% of Holdings
9.5%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
17,924
Price
$34.44
Total Value
$617.30K
Shares Held After
174,144
% of Holdings
9.3%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
165,408
Price
$33.63
Total Value
$5.56M
Shares Held After
477,783
% of Holdings
25.7%
BIOMARIN PHARMACEUTICAL INC (BMRN)
Davis George Eric — EVP, Chief Legal Officer
Shares
26,061
Price
$61.36
Total Value
$1.60M
Shares Held After
72,453
% of Holdings
26.5%
BIOMARIN PHARMACEUTICAL INC (BMRN)
Friberg Gregory R — EVP, Chief R&D Officer
Shares
6,326
Price
$60.38
Total Value
$381.94K
Shares Held After
37,578
% of Holdings
14.4%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
2,638
Price
$276.32
Total Value
$728.92K
Shares Held After
85,096
% of Holdings
3.0%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
5,103
Price
$275.28
Total Value
$1.40M
Shares Held After
87,734
% of Holdings
5.5%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
12,378
Price
$23.86
Total Value
$295.34K
Shares Held After
639,076
% of Holdings
1.9%
Caribou Biosciences, Inc. (CRBU)
Kelly Timothy P — Chief Technology Officer
Shares
6,228
Price
$1.93
Total Value
$12.02K
Shares Held After
73,125
% of Holdings
7.8%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
523
Price
$18.04
Total Value
$9.43K
Shares Held After
209,641
% of Holdings
0.2%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
3,108
Price
$18.04
Total Value
$56.07K
Shares Held After
210,164
% of Holdings
1.5%
uniQure N.V. (QURE)
KLEMT CHRISTIAN — Chief Financial Officer
Shares
6,217
Price
$23.86
Total Value
$148.34K
Shares Held After
211,513
% of Holdings
2.9%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
942
Price
$28.90
Total Value
$27.22K
Shares Held After
170,273
% of Holdings
0.6%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
859
Price
$28.16
Total Value
$24.19K
Shares Held After
171,215
% of Holdings
0.5%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
1,437
Price
$26.98
Total Value
$38.77K
Shares Held After
172,074
% of Holdings
0.8%
Showing 51–100 of 936 transactions (page 2 of 19)